13F Pro Quality Score

66.8/100

Rank #499 of 2,879 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

76.4/100

Profitability

48.7/100

Balance Sheet

66.0/100

Earnings Quality

75.4/100

Free Cash Flow

39.5/100

Institutional Flow

56.1/100

Revenue Scale

99.6/100

Dilution Risk

88.2/100

CI Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Cigna Group (CI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CI at 66.8/100 on a 32-signal composite quality model, placing it at rank #499 of 2,879 stocks — the top 25% of the AI-ranked universe. CI scores in the top quartile across revenue scale (99.6), revenue growth (76.4), earnings quality (75.4). Areas of concern include free cash flow (39.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Cigna Group reports quarterly revenue of $68.5B, net income of $1.7B, an operating margin of 3.4%. CI trades on the NYSE exchange and files with the SEC under CIK 1739940. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cigna Group directly from SEC EDGAR.

Revenue

Q1 2026

$68.5B

Net Income

Q1 2026

$1.7B

Free Cash Flow

Q1 2026

$1.1B

Operating Margin

Q1 2026

3.4%

D/E Ratio

Q1 2026

0.73

Get alerted when CI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Cigna Group including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put CI on your watchlist

Track score changes the day Cigna Group files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CI a good stock to buy?

13F Pro's AI-powered analysis of Cigna Group (CI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CI are available on the CI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cigna Group's investment landscape.